Mood stabilizers for perimenopause mood: does it work?

Mood stabilizers aren't well studied for perimenopause mood on their own, and no guideline lists them as a first option.

The stronger evidence is for SSRIs, certain hormonal treatments and CBT, which guidelines on mood and anxiety disorders across reproductive transitions do recommend (Obstetrics and Gynecology clinical review, 2017). Mood stabilizers such as lithium, lamotrigine or valproate are usually considered only when someone also has a diagnosed mood disorder like bipolar disorder, or when other options haven't worked, under a psychiatrist's care.

• SSRIs: stronger evidence base for perimenopausal mood symptoms
• Hormonal options (like HRT): can ease mood alongside hot flashes and sleep problems
• CBT: evidence-backed, no medication side effects
• Mood stabilizers: used mainly for diagnosed bipolar disorder, not perimenopause mood alone

For the fuller picture on first-line options, see perimenopause mood swing treatment.

Most research on perimenopause mood looks at why it happens, not which drug treats it best. A 2021 review found that some women with a history of premenstrual dysphoric disorder (PMDD) become more sensitive to hormone withdrawal as they approach the menopause transition, and their mood symptoms can resurface or worsen (Current Psychiatry Reports, 2021).

A meta-analysis pooling 5,129 women found no consistent difference in HPO-axis hormone or gene markers between women with perimenopausal depression and women without it, unlike the clearer pattern seen in PMDD (Frontiers in Neuroendocrinology, 2021).

A 2026 systematic review describes this as a hormone-sensitivity model, where hormone levels stay normal but the brain's response to them differs (Natural Resources for Human Health, 2026). None of these papers tested a mood stabilizer directly.

The Harvard Study of Moods and Cycles, which followed 976 women, found that those with more depressive symptoms at enrollment had about twice the risk of an earlier perimenopause transition (Archives of General Psychiatry, 2003). That's a reason doctors watch mood closely during this transition, even though it doesn't tell us which medication works best.

There's no controlled perimenopause-specific timeline for mood stabilizers, because they're rarely used as a first treatment for this kind of mood change. In other conditions, lamotrigine is started low and raised slowly over weeks to lower the risk of a serious rash, so it isn't fast-acting. Lithium needs regular blood tests to find a safe, effective level, which also takes time.

If you're perimenopausal and a doctor does prescribe a mood stabilizer, it's almost always because another condition, often bipolar disorder, is being treated alongside the mood changes. The timeline then follows that condition's usual course, not a quick, cycle-timed response.

Compare that with SSRIs, which some people take only in the days before symptoms are expected in a regular cycle. That dosing pattern doesn't carry over once periods become irregular in perimenopause, which is part of why treatment often shifts during this transition.

Side effects vary by which mood stabilizer is used, and none of them are specific to perimenopause. They're the same risks seen whenever these drugs are prescribed for any reason.

A doctor who prescribes one of these checks blood levels or organ function regularly, not just when you start. That ongoing monitoring is part of why mood stabilizers aren't an easy first step for perimenopause mood, when SSRIs or hormonal treatment often do the job with less follow-up.

Some mood stabilizers carry risks that matter more for some people than others.

• Valproate carries a high risk of birth defects, so it generally isn't given to anyone who could become pregnant.
• Lithium needs monitoring in anyone with kidney or thyroid problems, since the drug affects both.
• Lamotrigine's rash risk means a new or spreading rash while taking it needs quick medical attention.
• If your mood symptoms are mostly confined to the week or two before a period and ease once it starts, a mood stabilizer usually isn't the right first step.

That last pattern points toward PMS or PMDD, which have their own evidence-backed options. See mood stabilizers for PMDD for how the evidence differs there.

If you had PMDD or a strong premenstrual mood pattern before perimenopause started, a specialist who treats both is worth finding, since that history can shape how the transition goes. See finding a PMDD specialist.

Tracking your mood daily still helps, even as your cycle gets less predictable. The DRSP chart was built for regular cycles, but a doctor can adapt it to track by date instead of cycle day.

For the wider research on how mood stabilizers perform across conditions, not just perimenopause, see mood stabilizers and mood and our research hub.

Sleep, regular movement and a consistent routine won't replace medication. They can lower the daily load while you and your doctor work out what helps.

Right now, before any medication plan is in place, you need something that works in minutes, not weeks.

1. Leave the room if you're mid-argument, and tell the other person you'll be back in 20 minutes.
2. Breathe out for six counts, longer than you breathe in, to calm your body down.
3. Write down what happened while it's fresh, so you don't lose the details by morning.

Niyora is a PMS and PMDD support app. If your mood still swings around your old cycle dates even as periods become irregular, Niyora's Moon lets you write down what happened, see it from another angle and draft a reply you can hold onto for 20 minutes before you send anything.